[A severe course of bullous pemphigoid in a young man].
Eigelshoven
S
S
Hautklinik der Heinrich-Heine-Universität, Düsseldorf.
Bruch-Gerharz
D
D
Enderlein
E
E
Ruzicka
T
T
Büchau
A S
AS
Hertl
M
M
Reifenberger
J
J
Schulte
K-W
KW
D000328:Adult; D001323:Autoantibodies / Q000032:analysis; D001324:Autoantigens / Q000276:immunology; D001485:Basement Membrane / Q000473:pathology; D001706:Biopsy; D003131:Combined Modality Therapy; D003176:Complement C3 / Q000032:analysis; D003937:Diagnosis, Differential; D018450:Disease Progression; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008856:Microscopy, Fluorescence; D024041:Non-Fibrillar Collagens / Q000276:immunology; D010391:Pemphigoid, Bullous / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D010956:Plasmapheresis; D012867:Skin / Q000473:pathology; D000097805:Collagen Type XVII
D001323:Autoantibodies; D001324:Autoantigens; D003176:Complement C3; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D024041:Non-Fibrillar Collagens; D000097805:Collagen Type XVII